Skip to content

13F-HR filed by BVF INC/IL

BVF INC/IL filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 21:01:10 UTC, with 47 holding rows worth $3,040,139,878.

Accession
0000921895-26-003162
Filed
2026-11-16
Accepted by EDGAR
Ingested
Source
EDGAR daily index

Original filing

13F report for Q3 2026

A holdings report, 47 entries on the cover page, a total value of $3,040,139,878 stated on the cover page (in dollars after the unit check, H1), rows summing to $3,040,139,878 with VALUE read as dollars as filed, 13F file number 028-06800. The quarter's positions are built on this report. The resolved quarter.

Other managers

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
REVOLUTION MEDICINES INC COM76155X100Stock2,460,560$505,054,546dollars as filed
KYMERA THERAPEUTICS INC501575104COM3,872,052$432,856,693dollars as filed
GH RESEARCH PLC ORDINARY SHARESG3855L106Stock8,650,158$203,105,710dollars as filed
MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD61559X104Stock16,001,284$187,215,023dollars as filed
XENCOR INC98401F105COMMON STOCK6,227,034$155,364,498dollars as filed
NEKTAR THERAPEUTICS640268306COMMON STOCK2,134,007$129,203,454dollars as filed
ALKERMES PLCG01767105SHS2,847,100$115,364,492dollars as filed
STOKE THERAPEUTICS INC86150R107COM3,608,968$93,833,168dollars as filed
TYRA BIOSCIENCES INC90240B106COMMON STOCK4,215,886$92,201,427dollars as filed
ZYMEWORKS INC98985Y108COM3,464,142$91,765,122dollars as filed
CULLINAN THERAPEUTICS INC230031106COM5,750,683$88,272,984dollars as filed
STRUCTURE THERAPEUTICS INC COMP86366E106EQUITY2,691,426$84,160,891dollars as filed
PALVELLA THERAPEUTICS INC697947109COMMON STOCK607,149$83,744,062dollars as filed
KURA ONCOLOGY INC COM50127T109Stock6,690,108$71,651,057dollars as filed
AC IMMUNE SAH00263105SHS19,822,436$51,934,782dollars as filed
MONTE ROSA THERAPEUTICS INC61225M102COM4,276,578$51,019,576dollars as filed
ENTERA BIO LTDM40527109SHS17,052,893$49,623,919dollars as filed
OLEMA PHARMACEUTICALS INC68062P106COM5,295,893$45,756,516dollars as filed
CRESCENT BIOPHARMA INCG2545C104COMMON STOCK3,093,590$45,135,478dollars as filed
4D MOLECULAR THERAPEUTICS INC COM35104E100Stock2,879,289$41,202,626dollars as filed
IMMUNOCORE HLDGS PLC ADS45258D105ADR1,230,909$37,284,234dollars as filed
ANNEXON INC03589W102COM8,278,164$35,016,634dollars as filed
MIRUM PHARMACEUTICALS INC604749101COM407,226$34,809,678dollars as filed
SAGIMET BIOSCIENCES INC A786700104COMMON STOCK3,500,000$34,580,000dollars as filed
PYXIS ONCOLOGY INC COMMON STOCK747324101Stock11,826,140$27,554,906dollars as filed
ABSCI CORPORATION00091E109COM2,361,674$25,435,229dollars as filed
INVIVYD INC00534A102COMMON STOCK28,165,000$24,506,367dollars as filed
ANTERIS TECHNOLOGIES GLOBAL03675P102COMMON STOCK3,000,000$23,310,000dollars as filed
FOGHORN THERAPEUTICS INC344174107COMMON STOCK5,842,000$20,855,940dollars as filed
SUTRO BIOPHARMA INC869367201COMMON STOCK1,251,788$20,166,305dollars as filed
Q32 BIO INC746964105Common Stock2,350,000$19,434,500dollars as filed
ALECTOR INC014442107COMMON STOCK10,046,206$18,585,481dollars as filed
ELEDON PHARMACEUTICALS INC28617k101COM6,293,282$15,922,003dollars as filed
DISC MEDICINE INC COM254604101Stock233,300$15,271,818dollars as filed
AVALO THERAPEUTICS INC05338F306COMMON STOCK907,406$13,910,534dollars as filed
ONKURE THERAPEUTICS INC68277Q105COM CL A4,045,278$11,023,383dollars as filed
IMMUNIC INC4525EP200COM NEW765,295$7,117,244dollars as filed
TCGX ACQUISITION CORPG8708J109COM500,000$6,255,000dollars as filed
RESEARCH ALLIANCE CORP IVG75228109CL A ORD SHS500,000$5,920,000dollars as filed
Research Alliance Corp Iii Ord Shs Cl AG75226103Common Stock500,000$5,355,000dollars as filed
MOLECULAR PARTNERS AG60853G106ADS1,353,968$5,185,697dollars as filed
IMAGENEBIO INC45175G207CMN1,110,002$5,083,809dollars as filed
X4 PHARMACEUTICALS INC98420X202COMMON STOCK1,576,624$4,572,210dollars as filed
INVENTIVA SA46124U107ADS686,040$2,531,488dollars as filed
Tscan Therapeutics Inc89854M101COM5,564,290$1,749,969dollars as filed
Engene Therapeutics Inc W Exp 10/31/20229286X119SPAC Combination945,402$189,175dollars as filed
TENAX THERAPEUTICS INC88032L605COM NEW25,000$47,250dollars as filed

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0000921895-26-003162this filing2026-11-16